sulfan blue has been researched along with Atypical Ductal Hyperplasia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alves, M; Azevedo, JP; Ribeiro, C; Todo Bom, A | 1 |
Bando, E; Michigishi, T; Minato, H; Miwa, K; Nakajima, K; Noguchi, M; Nonomura, A; Tonami, N; Tsugawa, K; Yokoyama, K | 1 |
2 other study(ies) available for sulfan blue and Atypical Ductal Hyperplasia
Article | Year |
---|---|
Anaphylactic shock perioperative to patent blue dye.
Topics: Anaphylaxis; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Coloring Agents; Diagnosis, Differential; Female; Humans; Lymph Nodes; Mastectomy; Middle Aged; Perioperative Period; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin Tests; Treatment Outcome | 2018 |
Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
Topics: Adult; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Coloring Agents; Female; Humans; Intraoperative Care; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Particle Size; Preoperative Care; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin | 2000 |